AbbVie Historical Income Statement

ABBV Stock  USD 181.09  0.74  0.41%   
Historical analysis of AbbVie income statement accounts such as Interest Expense of 1.1 B, Selling General Administrative of 8 B or Total Revenue of 33.8 B can show how well AbbVie Inc performed in making a profits. Evaluating AbbVie income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AbbVie's future profits or losses.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining AbbVie Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AbbVie Inc is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About AbbVie Income Statement Analysis

AbbVie Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AbbVie shareholders. The income statement also shows AbbVie investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

AbbVie Income Statement Chart

AbbVie Inc Income Statement is one of the three primary financial statements used for reporting AbbVie's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AbbVie Inc revenue and expense. AbbVie Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, AbbVie's Depreciation And Amortization is fairly stable compared to the past year. Income Before Tax is likely to climb to about 7.3 B in 2024, whereas Selling General Administrative is likely to drop slightly above 8 B in 2024.

Total Revenue

Total revenue comprises all receipts AbbVie Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of AbbVie Inc minus its cost of goods sold. It is profit before AbbVie operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AbbVie Inc. It is also known as AbbVie overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from AbbVie's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AbbVie Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
At this time, AbbVie's Depreciation And Amortization is fairly stable compared to the past year. Income Before Tax is likely to climb to about 7.3 B in 2024, whereas Selling General Administrative is likely to drop slightly above 8 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit38.8B40.6B45.5B25.2B
Total Revenue56.2B58.1B54.3B33.8B

AbbVie income statement Correlations

0.750.840.860.840.860.580.470.490.730.80.80.49-0.630.560.020.60.79-0.67-0.2-0.42-0.870.970.75-0.990.98
0.750.790.950.90.930.60.580.760.770.920.810.59-0.290.7-0.070.730.79-0.82-0.38-0.81-0.90.820.84-0.710.75
0.840.790.920.930.940.630.480.60.740.780.940.44-0.50.50.010.530.72-0.59-0.16-0.45-0.750.90.7-0.840.87
0.860.950.920.980.990.730.630.720.860.90.920.62-0.460.710.010.730.8-0.72-0.25-0.68-0.890.930.84-0.850.89
0.840.90.930.980.970.770.620.730.840.810.960.58-0.570.640.060.660.74-0.66-0.2-0.63-0.820.910.82-0.840.88
0.860.930.940.990.970.640.540.760.790.90.940.53-0.420.63-0.090.660.83-0.71-0.33-0.65-0.880.920.85-0.840.88
0.580.60.630.730.770.640.930.440.930.530.640.85-0.660.790.550.790.26-0.230.33-0.48-0.50.650.52-0.650.62
0.470.580.480.630.620.540.930.390.920.570.450.96-0.450.910.560.910.17-0.190.34-0.55-0.470.520.45-0.520.46
0.490.760.60.720.730.760.440.390.510.60.780.33-0.30.47-0.270.50.5-0.46-0.55-0.73-0.570.50.84-0.440.47
0.730.770.740.860.840.790.930.920.510.780.70.91-0.50.90.390.910.5-0.430.16-0.6-0.720.80.63-0.760.74
0.80.920.780.90.810.90.530.570.60.780.710.64-0.160.76-0.10.780.85-0.76-0.32-0.7-0.940.850.76-0.750.78
0.80.810.940.920.960.940.640.450.780.70.710.38-0.560.46-0.070.480.71-0.58-0.3-0.53-0.730.850.8-0.790.84
0.490.590.440.620.580.530.850.960.330.910.640.38-0.320.960.550.950.22-0.230.31-0.57-0.520.540.42-0.540.47
-0.63-0.29-0.5-0.46-0.57-0.42-0.66-0.45-0.3-0.5-0.16-0.56-0.32-0.26-0.3-0.31-0.190.23-0.140.090.34-0.54-0.490.69-0.63
0.560.70.50.710.640.630.790.910.470.90.760.460.96-0.260.280.990.39-0.380.05-0.63-0.670.610.59-0.580.52
0.02-0.070.010.010.06-0.090.550.56-0.270.39-0.1-0.070.55-0.30.280.28-0.380.340.88-0.060.20.02-0.34-0.110.04
0.60.730.530.730.660.660.790.910.50.910.780.480.95-0.310.990.280.4-0.40.03-0.65-0.690.630.63-0.610.55
0.790.790.720.80.740.830.260.170.50.50.850.710.22-0.190.39-0.380.4-0.85-0.53-0.47-0.920.850.74-0.730.82
-0.67-0.82-0.59-0.72-0.66-0.71-0.23-0.19-0.46-0.43-0.76-0.58-0.230.23-0.380.34-0.4-0.850.560.540.87-0.7-0.740.61-0.67
-0.2-0.38-0.16-0.25-0.2-0.330.330.34-0.550.16-0.32-0.30.31-0.140.050.880.03-0.530.560.240.43-0.19-0.610.1-0.17
-0.42-0.81-0.45-0.68-0.63-0.65-0.48-0.55-0.73-0.6-0.7-0.53-0.570.09-0.63-0.06-0.65-0.470.540.240.59-0.45-0.610.36-0.38
-0.87-0.9-0.75-0.89-0.82-0.88-0.5-0.47-0.57-0.72-0.94-0.73-0.520.34-0.670.2-0.69-0.920.870.430.59-0.9-0.840.83-0.86
0.970.820.90.930.910.920.650.520.50.80.850.850.54-0.540.610.020.630.85-0.7-0.19-0.45-0.90.76-0.960.99
0.750.840.70.840.820.850.520.450.840.630.760.80.42-0.490.59-0.340.630.74-0.74-0.61-0.61-0.840.76-0.720.73
-0.99-0.71-0.84-0.85-0.84-0.84-0.65-0.52-0.44-0.76-0.75-0.79-0.540.69-0.58-0.11-0.61-0.730.610.10.360.83-0.96-0.72-0.98
0.980.750.870.890.880.880.620.460.470.740.780.840.47-0.630.520.040.550.82-0.67-0.17-0.38-0.860.990.73-0.98
Click cells to compare fundamentals

AbbVie Account Relationship Matchups

AbbVie income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization812M6.5B8.5B8.5B8.7B9.1B
Interest Expense1.5B2.3B2.4B2.2B1.7B1.1B
Selling General Administrative5.8B9.5B10.2B13.3B12.9B8.0B
Total Revenue33.3B45.8B56.2B58.1B54.3B33.8B
Gross Profit25.8B30.4B38.8B40.6B45.5B25.2B
Other Operating Expenses19.9B33.2B37.3B39.2B36.9B23.2B
Operating Income13.0B476M17.9B18.1B17.4B9.4B
Ebit13.0B476M17.9B18.1B9.4B8.8B
Research Development6.4B6.6B7.1B6.5B7.0B5.4B
Ebitda13.8B6.9B26.4B26.6B18.1B12.0B
Cost Of Revenue7.4B15.4B17.4B17.4B8.8B8.7B
Total Operating Expenses12.5B17.9B19.9B21.8B28.1B14.5B
Income Before Tax8.4B3.4B13.0B13.5B6.3B7.3B
Total Other Income Expense Net(4.6B)2.9B(3.5B)(3.3B)(11.2B)(10.6B)
Net Income7.9B4.6B11.5B11.8B4.9B6.3B
Income Tax Expense544M(1.2B)1.4B1.6B1.4B996.2M
Net Income Applicable To Common Shares7.9B4.6B11.5B11.8B13.6B14.3B
Net Income From Continuing Ops7.9B4.6B11.5B11.8B4.9B6.9B
Non Recurring385M1.2B962M697M801.6M553.6M
Non Operating Income Net Other(3.0B)(5.7B)(2.6B)(2.6B)(2.3B)(2.5B)
Tax Provision544M(1.2B)1.4B1.6B1.4B811.5M
Interest Income275M174M39M186M540M567M
Net Interest Income(1.5B)(2.3B)(2.4B)(2.0B)(1.7B)(1.8B)
Reconciled Depreciation2.0B6.5B8.5B8.5B8.7B5.9B

Pair Trading with AbbVie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.

Moving together with AbbVie Stock

  0.89EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against AbbVie Stock

  0.9MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.9VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.82KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.8DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.